Hongying You, Zhi Yan, Yingying Zhai, Weiqin Yao, Shuang Yan, Xiaolan Shi, JingJing Shang, Song Jin, Lingzhi Yan, Depei Wu, Chengcheng Fu. "Treatment of high-risk newly diagnosed multiple myeloma with minimal residual disease-guided therapy:daratumumab, carfilzomib, lenalidomide, and dexamethasone (DKRd)." Blood (2025). https://doi.org/10.1182/blood-2025-5782